Healthcare Industry News: AGA Medical
News Release - August 28, 2006
AGA Medical Files Suit in Germany Alleging Patent Infringement
MINNEAPOLIS, Aug. 28 (HSMN NewsFeed) -- AGA Medical Corporation ("AGA") today announced that it has filed a patent infringement lawsuit against Occlutech GmbH, headquartered in Jena, Germany, and DRABO Medizintechnik, located in Cologne Germany. AGA is the owner of a European patent (EP 0 808 138) validated in Germany (DE 695 34 505) for intravascular occlusion devices and the method of forming or manufacturing these medical devices. The patent issued in October 2005. The action, filed in Dusseldorf, requests damages against Occlutech, DRABO, their CEOs and further requests a permanent injunction prohibiting them from manufacturing and marketing infringing "Figulla Occluder."ABOUT AGA Medical: AGA Medical Corporation, based in Golden Valley, Minnesota (just outside Minneapolis) is the leader in developing interventional devices to treat structural heart defects. As a result of the many contributions and creative genius of Dr. Kurt Amplatz, the Company has developed and commercializes a series of devices that have revolutionized the treatment of the most common congenital "holes in the heart" such as atrial septal and patent foramen ovale defects. Over 500 articles have been published in peer reviewed medical publications that support the benefits of AGA Medical devices including improved patient outcomes, reduced length of stay and accelerated recovery times for the patient, AGA Medical devices have received regulatory approval and are marketed in over 90 countries with over 190,000 devices shipped to date. For more information visit http://www.amplatzer.com
Source: AGA Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
